ALAN TAETLE

Alan Taetle stands as a distinguished General Partner at Noro-Moseley Partners, a prominent venture capital firm renowned for its strategic investments in high-growth companies. With a career spanning decades in finance and venture capital, Alan has established himself as a key figure in the investment landscape, particularly within the technology sector.

At Noro-Moseley Partners, Alan Taetle plays a pivotal role in sourcing, evaluating, and managing investments. His primary focus areas include healthcare IT, B2B software, and tech-enabled services. He possesses a keen eye for disruptive technologies and business models that offer significant market potential and sustainable competitive advantages. Alan is deeply involved with his portfolio companies, offering strategic guidance, operational insights, and leveraging his vast network to foster their growth and success.

Alan's career background is marked by a strong foundation in both consulting and investment banking before transitioning into venture capital. Prior to joining Noro-Moseley Partners in 1999, he gained valuable experience in venture capital at the Robinson-Humphrey Company. His earlier career included roles in investment banking at Bowles Hollowell Conner & Co. and management consulting at McKinsey & Company. This diverse background equipped him with a comprehensive understanding of business strategy, financial analysis, and market dynamics, which he effectively applies in his investment decisions today. Alan holds an MBA from Harvard Business School and a BA from the University of North Carolina at Chapel Hill.

Throughout his tenure at Noro-Moseley Partners, Alan Taetle has been instrumental in numerous successful investments and exits. His notable investments include companies like Brightree, a leading provider of cloud-based software for the post-acute care market, which was acquired by ResMed. He also played a key role in Medfusion, a patient portal and health management solution acquired by Allscripts, and Healthland, a rural hospital EHR provider acquired by CPSI. Other significant investments under his guidance include Medicity (acquired by Aetna), Scribe Healthcare Technologies (acquired by Nuance), Liaison Technologies (acquired by OpenText), and Virtustream (acquired by EMC). These successes underscore his ability to identify promising ventures and guide them towards lucrative outcomes, generating substantial returns for investors and fostering innovation within their respective industries.

Alan Taetle's commitment to fostering innovation and supporting entrepreneurial talent makes him a respected leader in the venture capital community. His strategic vision and hands-on approach continue to drive the success of Noro-Moseley Partners' portfolio and contribute significantly to the evolution of the technology and healthcare sectors.